These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23549374)

  • 1. Influence of type of nocturia and lower urinary tract symptoms on therapeutic outcome in women treated with desmopressin.
    Jeong JY; Kim SJ; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
    Korean J Urol; 2013 Feb; 54(2):95-9. PubMed ID: 23549374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Berges R; Höfner K; Gedamke M; Oelke M
    World J Urol; 2014 Oct; 32(5):1163-70. PubMed ID: 25135845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
    J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL; Huang YH; Hung TW; Ou YC
    Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [INITIAL TREATMENT OF NOCTURIA CAUSED BY NOCTURNAL POLYURIA WITH LOW-DOSE DESMOPRESSIN].
    Hayashi K; Fuji K; Omizu M; Hiramatsu A; Koizumi S; Matsubara E; Saito K; Yamagishi M; Sasaki H; Fukagai T; Ishikawa K; Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(1):18-24. PubMed ID: 35046231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES; Raymond K; Andruczyk E; Juul KV
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder and nocturia, current clinical features and outcomes: A systematic review.
    Barakat B; Franke K; May M; Gauger U; Vögeli TA
    Asian J Urol; 2022 Jan; 9(1):27-34. PubMed ID: 35198394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
    Peyronnet B; Brucker BM; Michel MC
    Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria].
    Terada N; Arakaki R; Okada Y; Kitahara M; Kaneko Y; Omori K; Nishimura K
    Hinyokika Kiyo; 2005 Mar; 51(3):151-4. PubMed ID: 15852666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity.
    Lee HW; Choo MS; Lee JG; Park CH; Paick JS; Lee JZ; Han DH; Park WH; Lee KS
    J Korean Med Sci; 2010 Dec; 25(12):1792-7. PubMed ID: 21165296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial.
    Torimoto K; Miyake M; Nakai Y; Aoki K; Tanaka N; Fujimoto K
    BMC Urol; 2020 Jul; 20(1):96. PubMed ID: 32652972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
    Weiss JP; van der Meulen EA; Juul KV
    Eur Urol Focus; 2020 Sep; 6(5):1006-1012. PubMed ID: 30470646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.
    Wang CJ; Lin YN; Huang SW; Chang CH
    J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them?
    Drangsholt S; Ruiz MJA; Peyronnet B; Rosenblum N; Nitti V; Brucker B
    World J Urol; 2019 Jul; 37(7):1389-1394. PubMed ID: 30288596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O; Juul KV; Falahati A; Yoshimura T; Imura F; Kitamura M
    Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
    Chung E
    Expert Opin Pharmacother; 2018 Feb; 19(3):291-298. PubMed ID: 29376448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.